. | Prediction models (N = 15) . | |
---|---|---|
no. . | % . | |
Patient-related: | ||
Performance status (ECOG or KPS) | 5 | 33.3 |
Age | 2 | 13.3 |
Diastolic BP | 2 | 13.3 |
Significant weight loss | 2 | 13.3 |
BMI | 2 | 13.3 |
Psychological stress or acute disease | 1 | 6.7 |
DPYD status | 1 | 6.7 |
5-FU-DR | 1 | 6.7 |
Social support | 1 | 6.7 |
Fluid consumption | 1 | 6.7 |
Sex | 1 | 6.7 |
Disease-related: | ||
Cancer stage | 3 | 20.0 |
Cancer type | 3 | 20.0 |
Treatment-related: | ||
MAX2 toxicity score | 5 | 33.3 |
Number of chemotherapies | 4 | 26.7 |
Dose of chemotherapy | 3 | 20.0 |
Poly/mono chemotherapy | 2 | 13.3 |
Use of particular chemotherapy | 1 | 6.7 |
Time from diagnosis to first chemotherapy | 1 | 6.7 |
Treatment duration | 1 | 6.7 |
Geriatric assessment: | ||
Functioning | ||
ALD or IADL | 6 | 40.0 |
Limitation in walking | 2 | 13.3 |
Falls number | 2 | 13.3 |
Grip strength | 1 | 6.7 |
Social activities | 1 | 6.7 |
Hearing impairment | 1 | 6.7 |
Cognition | ||
MMS | 2 | 13.3 |
Limitation of daily life due to dementia | 1 | 6.7 |
Ability to obey command | 1 | 6.7 |
Nutrition | ||
MNA | 2 | 13.3 |
CONUT | 1 | 6.7 |
Others | ||
CCI or co-morbidities | 2 | 13.3 |
Health perception | 1 | 6.7 |
Laboratory: | ||
Creatinine clearance | 4 | 26.7 |
Haemoglobin | 4 | 26.7 |
Serum albumin | 3 | 20.0 |
Lactate dehydrogenase | 3 | 20.0 |
White cell count | 1 | 6.7 |
Platelet count | 1 | 6.7 |
Liver function | 1 | 6.7 |
C-reactive protein | 1 | 6.7 |
Protein | 1 | 6.7 |
. | Prediction models (N = 15) . | |
---|---|---|
no. . | % . | |
Patient-related: | ||
Performance status (ECOG or KPS) | 5 | 33.3 |
Age | 2 | 13.3 |
Diastolic BP | 2 | 13.3 |
Significant weight loss | 2 | 13.3 |
BMI | 2 | 13.3 |
Psychological stress or acute disease | 1 | 6.7 |
DPYD status | 1 | 6.7 |
5-FU-DR | 1 | 6.7 |
Social support | 1 | 6.7 |
Fluid consumption | 1 | 6.7 |
Sex | 1 | 6.7 |
Disease-related: | ||
Cancer stage | 3 | 20.0 |
Cancer type | 3 | 20.0 |
Treatment-related: | ||
MAX2 toxicity score | 5 | 33.3 |
Number of chemotherapies | 4 | 26.7 |
Dose of chemotherapy | 3 | 20.0 |
Poly/mono chemotherapy | 2 | 13.3 |
Use of particular chemotherapy | 1 | 6.7 |
Time from diagnosis to first chemotherapy | 1 | 6.7 |
Treatment duration | 1 | 6.7 |
Geriatric assessment: | ||
Functioning | ||
ALD or IADL | 6 | 40.0 |
Limitation in walking | 2 | 13.3 |
Falls number | 2 | 13.3 |
Grip strength | 1 | 6.7 |
Social activities | 1 | 6.7 |
Hearing impairment | 1 | 6.7 |
Cognition | ||
MMS | 2 | 13.3 |
Limitation of daily life due to dementia | 1 | 6.7 |
Ability to obey command | 1 | 6.7 |
Nutrition | ||
MNA | 2 | 13.3 |
CONUT | 1 | 6.7 |
Others | ||
CCI or co-morbidities | 2 | 13.3 |
Health perception | 1 | 6.7 |
Laboratory: | ||
Creatinine clearance | 4 | 26.7 |
Haemoglobin | 4 | 26.7 |
Serum albumin | 3 | 20.0 |
Lactate dehydrogenase | 3 | 20.0 |
White cell count | 1 | 6.7 |
Platelet count | 1 | 6.7 |
Liver function | 1 | 6.7 |
C-reactive protein | 1 | 6.7 |
Protein | 1 | 6.7 |
Abbreviations: ADL, activities of daily living. BMI, body mass index. BP, blood pressure. CCI, Charlson comorbidity score. CONUT, controlling nutritional status. DPYD, dihydropyrimidine dehydrogenase, ECOG, eastern cooperative oncology group. 5-FU-DR, 5-fluorouracil degradation rate. IADL, instrumental activities of daily living. KPS, Karnofsky performance scale. MNA, mini nutritional assessment. MMS, Mini-mental state.
. | Prediction models (N = 15) . | |
---|---|---|
no. . | % . | |
Patient-related: | ||
Performance status (ECOG or KPS) | 5 | 33.3 |
Age | 2 | 13.3 |
Diastolic BP | 2 | 13.3 |
Significant weight loss | 2 | 13.3 |
BMI | 2 | 13.3 |
Psychological stress or acute disease | 1 | 6.7 |
DPYD status | 1 | 6.7 |
5-FU-DR | 1 | 6.7 |
Social support | 1 | 6.7 |
Fluid consumption | 1 | 6.7 |
Sex | 1 | 6.7 |
Disease-related: | ||
Cancer stage | 3 | 20.0 |
Cancer type | 3 | 20.0 |
Treatment-related: | ||
MAX2 toxicity score | 5 | 33.3 |
Number of chemotherapies | 4 | 26.7 |
Dose of chemotherapy | 3 | 20.0 |
Poly/mono chemotherapy | 2 | 13.3 |
Use of particular chemotherapy | 1 | 6.7 |
Time from diagnosis to first chemotherapy | 1 | 6.7 |
Treatment duration | 1 | 6.7 |
Geriatric assessment: | ||
Functioning | ||
ALD or IADL | 6 | 40.0 |
Limitation in walking | 2 | 13.3 |
Falls number | 2 | 13.3 |
Grip strength | 1 | 6.7 |
Social activities | 1 | 6.7 |
Hearing impairment | 1 | 6.7 |
Cognition | ||
MMS | 2 | 13.3 |
Limitation of daily life due to dementia | 1 | 6.7 |
Ability to obey command | 1 | 6.7 |
Nutrition | ||
MNA | 2 | 13.3 |
CONUT | 1 | 6.7 |
Others | ||
CCI or co-morbidities | 2 | 13.3 |
Health perception | 1 | 6.7 |
Laboratory: | ||
Creatinine clearance | 4 | 26.7 |
Haemoglobin | 4 | 26.7 |
Serum albumin | 3 | 20.0 |
Lactate dehydrogenase | 3 | 20.0 |
White cell count | 1 | 6.7 |
Platelet count | 1 | 6.7 |
Liver function | 1 | 6.7 |
C-reactive protein | 1 | 6.7 |
Protein | 1 | 6.7 |
. | Prediction models (N = 15) . | |
---|---|---|
no. . | % . | |
Patient-related: | ||
Performance status (ECOG or KPS) | 5 | 33.3 |
Age | 2 | 13.3 |
Diastolic BP | 2 | 13.3 |
Significant weight loss | 2 | 13.3 |
BMI | 2 | 13.3 |
Psychological stress or acute disease | 1 | 6.7 |
DPYD status | 1 | 6.7 |
5-FU-DR | 1 | 6.7 |
Social support | 1 | 6.7 |
Fluid consumption | 1 | 6.7 |
Sex | 1 | 6.7 |
Disease-related: | ||
Cancer stage | 3 | 20.0 |
Cancer type | 3 | 20.0 |
Treatment-related: | ||
MAX2 toxicity score | 5 | 33.3 |
Number of chemotherapies | 4 | 26.7 |
Dose of chemotherapy | 3 | 20.0 |
Poly/mono chemotherapy | 2 | 13.3 |
Use of particular chemotherapy | 1 | 6.7 |
Time from diagnosis to first chemotherapy | 1 | 6.7 |
Treatment duration | 1 | 6.7 |
Geriatric assessment: | ||
Functioning | ||
ALD or IADL | 6 | 40.0 |
Limitation in walking | 2 | 13.3 |
Falls number | 2 | 13.3 |
Grip strength | 1 | 6.7 |
Social activities | 1 | 6.7 |
Hearing impairment | 1 | 6.7 |
Cognition | ||
MMS | 2 | 13.3 |
Limitation of daily life due to dementia | 1 | 6.7 |
Ability to obey command | 1 | 6.7 |
Nutrition | ||
MNA | 2 | 13.3 |
CONUT | 1 | 6.7 |
Others | ||
CCI or co-morbidities | 2 | 13.3 |
Health perception | 1 | 6.7 |
Laboratory: | ||
Creatinine clearance | 4 | 26.7 |
Haemoglobin | 4 | 26.7 |
Serum albumin | 3 | 20.0 |
Lactate dehydrogenase | 3 | 20.0 |
White cell count | 1 | 6.7 |
Platelet count | 1 | 6.7 |
Liver function | 1 | 6.7 |
C-reactive protein | 1 | 6.7 |
Protein | 1 | 6.7 |
Abbreviations: ADL, activities of daily living. BMI, body mass index. BP, blood pressure. CCI, Charlson comorbidity score. CONUT, controlling nutritional status. DPYD, dihydropyrimidine dehydrogenase, ECOG, eastern cooperative oncology group. 5-FU-DR, 5-fluorouracil degradation rate. IADL, instrumental activities of daily living. KPS, Karnofsky performance scale. MNA, mini nutritional assessment. MMS, Mini-mental state.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.